Setting A New 52 Week Low, ENDRA Life Sciences Inc (Nasdaq:NDRA) Closing At $1.06

ENDRA Life Sciences Inc (Nasdaq:NDRA)

May 15th, 2019

With markets going up ENDRA Life Sciences Inc finished Wednesday’s trading session down 22.63%, a ($0.31) decrease to close on $1.06. As well as the drop in value, ENDRA Life Sciences Inc hit a new 52 week low of $1.02, breaking the previous low of $1.33 from earlier this month. ENDRA Life Sciences Inc bounced 29.41% between low and high. Be aware that the Altman Z-Score1 (An indicator of the probability for a 2-year bankruptcy) is below the recommended threshold of 1.8%, and calculated to be -2.10.

NDRA was outperformed by the rest of the Healthcare sector which went up 0.27%.

Market Sectors

The market sectors were mixed Wednesday with a majority of the sectors trending up. Communication Services saw the biggest increase of the day (2.11%), while Financials saw the biggest drop (-0.48%). Information Technology has seen the biggest year-to-date gain at 19.93%.

Communication Services saw the biggest turnaround from its 5-day performance of -2.60%, as it went up 2.11%. Utilities saw a turn around from its 5-day performance of 0.47% trading down -0.13%.

Sector Breakdown

  • Communication Services went up with a 2.11% change.
  • Information Technology went up with a 0.98% change.
  • Consumer Staples went up with a 0.80% change.
  • Consumer Discretionary went up with a 0.78% change.
  • Real Estate went up with a 0.64% change.
  • Energy went up with a 0.46% change.
  • Healthcare went up with a 0.27% change.
  • Industrials went up with a 0.12% change.
  • Utilities went down with a -0.13% change.
  • Materials went down with a -0.24% change.
  • Financials went down with a -0.48% change.

ENDRA Life Sciences Inc Info

ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person’s body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.

All amounts in USD unless otherwise indicated

(1) The Altman Z-Score calculation was first published in 1968 by Edward I. Altman, and is used for predicting the probability that a firm will go into bankruptcy within two years. An Altman Z-Score below 1.8 (Remember that ENDRA Life Sciences Inc’s score is -2.10) is the trigger to be alert for this situation. Some analysts believe this score is less relevant for some companies, in particular companies operating to accumulate users that may run at huge losses to scale up.

NDRA daily update
NDRA daily update

Photo by Kat J on Unsplash

Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.

Tell us what you think